Synergy Pharmaceuticals Announces Closing of Public Offering of Shares of Common Stock
[at noodls] – NEW YORK, April 16, 2013 — Synergy Pharmaceuticals Inc.(Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced the closing of its underwritten public offering … moreView todays social media effects on SGYPWView the latest stocks trending across Twitter. Click to view dashboardSee who Synergy is hiring next, click here to view […]